Deep learning-based computed tomography quantification of left ventricular mass
- PMID: 39045069
- PMCID: PMC11195721
- DOI: 10.1093/ehjimp/qyad043
Deep learning-based computed tomography quantification of left ventricular mass
Conflict of interest statement
Conflict of interest. J.A., J.K., J.J., J.F., A.R.I., and G.D. have equity in Artrya Ltd. J.J., J.F., and S.K. are employees of Artrya Ltd. A.R.I. has speaker bureau from Boston Scientific, Abbott Medical, and Janssen. G.D. has speaker bureau for Janssen, Amgen, Pfizer, and AstraZeneca. For the remaining authors, none were declared.
Figures
References
-
- Klein R, Ametepe ES, Yam Y, Dwivedi G, Chow BJ. Cardiac CT assessment of left ventricular mass in mid-diastasis and its prognostic value. Eur Heart J Cardiovasc Imaging 2017;18:95–102. - PubMed
-
- Rockenbach MABC, Buch V, Gupta V, Kotecha GK, Laur O, Erdal BSet al. . Automatic detection of decreased ejection fraction and left ventricular hypertrophy on 4D cardiac CTA: use of artificial intelligence with transfer learning to facilitate multi-site operations. Intell-Based Med 2022;6:100051.
-
- Akram K, Anderson HD, Voros S. Quantification of left ventricular parameters obtained by automated software for 64-slice multidetector computed tomography and comparison with magnetic resonance imaging. Cardiovasc Intervent Radiol 2009;32:1154–60. - PubMed
LinkOut - more resources
Full Text Sources